Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry
In: Beneficial MicrobesSearch for other papers by M. Fredua-Agyeman in
Current site
Google Scholar
Search for other papers by S. Gaisford in
Current site
Google Scholar
The large number of probiotic products now available makes the decision about which product to choose difficult both for the consumer and for the specialist providing dietary/nutritional advice. Data on the viability of the bacteria in these products, in an in vivo situation, are therefore important. This study was designed to explore the comparative health and survival of probiotic species in various commercial formulations, using more realistic test systems. This might allow further understanding of factors that must be controlled to optimise the delivery of live healthy bacteria to the lower gut. A total of eight commercially available probiotic preparations were selected for enumeration tests and in vitro gastric tolerance tests. Tolerance assays were conducted in porcine gastric fluid (PGF) fed and fasted state (pH 3.4±0.04), simulated gastric fluid (SGF, pH adjusted to 1.2 and 3.4) and fasted state simulated gastric fluid (FaSSGF, pH adjusted to 1.6 and 3.4). Isothermal microcalorimetry was also used to measure real-time growth of probiotics after exposure to simulated gastric fluid. Results from the enumeration tests indicated that recovery of viable organisms per dose is the same as or better than the stated label claims for liquid-based formulations, but lower than the stated claim for freeze-dried products. Results from the in vitro tolerance tests overall suggest that the PGF provided a harsher environment than the simulated systems at similar pH. In general, liquid-based products tested tended to give superior results in terms of survival compared with the freeze-dried products tested. Results from tests in the fed state in PGF suggested that food greatly affects viability. Microcalorimetric data showed that for some products probiotic species were able to grow following exposure to gastric fluid, suggesting that viable bacteria reach the gut in vivo.
-
Aburub, A., Risley, D.S. and Mishra, D., 2008. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. International Journal of Pharmaceutics 347: 16-22.
'A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe ' () 347 International Journal of Pharmaceutics : 16 -22.
-
Aulton, M.E., 2013. Aulton's pharmaceutics: the design and manufacture of medicines. Churchill Livingstone, Edinburgh, Scotland.
Aulton's pharmaceutics: the design and manufacture of medicines , ().
-
Boling, E.A., Blanchard, G.C. and Russell, W.J., 1973. Bacterial identification by microcalorimetry. Nature 241: 472-473.
'Bacterial identification by microcalorimetry ' () 241 Nature : 472 -473.
-
Braissant, O., Wirz, D., Göpfert, B. and Daniels, A.U., 2010. Use of isothermal microcalorimetry to monitor microbial activities. FEMS Microbiology Letters 303: 1-8.
'Use of isothermal microcalorimetry to monitor microbial activities ' () 303 FEMS Microbiology Letters : 1 -8.
-
Braissant, O., Wirz, D., Göpfert, B. and Daniels, A.U., 2011. Biomedical use of isothermal microcalorimeters. Sensors 10: 9369-9383.
'Biomedical use of isothermal microcalorimeters ' () 10 Sensors : 9369 -9383.
-
British Pharmacopoeia, 2012. British Pharmacopoeia Volume V, Appendix XII B. Dissolution ANNEX: Recommendations on dissolution testing; Appendix I A. General reagents: gastric juice, artificial. TSO – Norwich, Norwich, UK.
-
Chandramouli, V., Kailasapathy, K., Peiris, P. and Jones, M., 2004. An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. Journal of Microbiological Methods 56: 27-35.
'An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions ' () 56 Journal of Microbiological Methods : 27 -35.
-
Charteris, W.P., Kelly, P.M., Morelli, L. and Collins J.K., 1998. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. Journal of Applied Microbiology 84: 759-768.
'Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract ' () 84 Journal of Applied Microbiology : 759 -768.
-
Cook, M.T., Tzortzis, G., Charalampopoulos, D. and Khutoryanskiy, V.V., 2011. Production and evaluation of dry alginatechitosan microcapsules as an enteric delivery vehicle for probiotic bacteria. Biomacromolecules, 12: 2834-2840.
'Production and evaluation of dry alginatechitosan microcapsules as an enteric delivery vehicle for probiotic bacteria ' () 12 Biomacromolecules : 2834 -2840.
-
Cook, M.T., Tzortzis, G., Charalampopoulos, D. and Khutoryanskiy, V.V., 2012. Microencapsulation of probiotics for gastrointestinal delivery. Journal of Controlled Release 162: 56-67.
'Microencapsulation of probiotics for gastrointestinal delivery ' () 162 Journal of Controlled Release : 56 -67.
-
Corcoran, B.M., Stanton, C., Fitzgerald, G.F. and Ross, R.P., 2005. Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Applied Environmental Microbiology 71: 3060-3067.
'Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars ' () 71 Applied Environmental Microbiology : 3060 -3067.
-
Cui, J.H., Goh, J.S., Kim, P.H., Choi, S.H. and Lee, B.J., 2000. Survival and stability of bifidobacteria loaded in alginate poly-l-lysine microparticles. International Journal of Pharmaceutics 210: 51-59.
'Survival and stability of bifidobacteria loaded in alginate poly-l-lysine microparticles ' () 210 International Journal of Pharmaceutics : 51 -59.
-
Ding, W.K. and Shah, N.P., 2009. An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage. Journal of Food Science 74: M53-M61.
'An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage ' () 74 Journal of Food Science : M53 -M61.
-
Dressman, J.B., Berardi, R.R., Dermentzoglou, L.C., Russell, T.L., Schmaltz, S.P., Barnett, J.L. and Jarvenpaa, K.M., 1990. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharmaceutical Research 7: 756-761.
'Upper gastrointestinal (GI) pH in young, healthy men and women ' () 7 Pharmaceutical Research : 756 -761.
-
Efentakis, M. and Dressman, J.B., 1998. Gastric juice as a dissolution medium: surface tension and pH. European Journal of Drug Metabolism and Pharmacokinetics 23: 97-102.
'Gastric juice as a dissolution medium: surface tension and pH ' () 23 European Journal of Drug Metabolism and Pharmacokinetics : 97 -102.
-
Evans, D.F., Pye, G., Bramley, R., Clark, A.G., Dyson, T.J. and Hardcastle, J.D., 1988. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29: 1035-1041.
'Measurement of gastrointestinal pH profiles in normal ambulant human subjects ' () 29 Gut : 1035 -1041.
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Report of the Joint FAO/ WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 1-4 October 2001, Córdoba, Argentina. FAO, Rome, Italy.
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Report of a joint FAO/ WHO working group on drafting guidelines for the evaluation of probiotics in food. April 30-May 1, 2002. London Ontario, Canada. FAO, Rome, Italy.
-
Food and Drug Administration (FDA), 2000. Waiver of the in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system: guidance for industry. FDA, Washington, DC, USA, pp. 1-13.
-
Food Commission, 2006. Do we need a daily dose of bacteria? Available at: http://www.foodcomm.org.uk/articles/dose_of_bacteria_06/. http://www.foodcomm.org.uk/articles/dose_of_bacteria_06/
-
Fordtran, J.S. and Walsh, J.H., 1973. Gastric-acid secretion rate and buffer content of stomach after eating results in normal subjects and in patients with duodenal-ulcer. Journal of Clinical Investigations 52: 645-657.
'Gastric-acid secretion rate and buffer content of stomach after eating results in normal subjects and in patients with duodenal-ulcer ' () 52 Journal of Clinical Investigations : 645 -657.
-
Gibson, G.R., Rouzaud, G., Brostoff, J. and Rayment, N., 2003. An evaluation of probiotic effects in the human gut: microbial aspects. Food Standards Agency Technical Report (G01022). FSA, London, UK. Available at: http://tinyurl.com/qxcvuad. http://tinyurl.com/qxcvuad
-
Granger, D.N., Barrowman, J.A. and Kvietys, P.R., 1985. Clinical gastrointestinal physiology. W.B. Saunders, Philadelphia, PA, USA.
Clinical gastrointestinal physiology , ().
-
Harrison, A.P. and Pelczar, M.J., 1963. Damage and survival of bacteria during freeze-drying and during storage over a ten-year period. Journal of General Microbiology 30: 395-400.
'Damage and survival of bacteria during freeze-drying and during storage over a ten-year period ' () 30 Journal of General Microbiology : 395 -400.
-
Hellmig, S., Von Schoning, F., Gadow, C., Katsoulis, S., Hedderich, J., Folsch, U.R. and Stuber, E., 2006. Gastric emptying time of fluids and solids in healthy subjects determined by l3C breath tests: influence of age, sex and body mass index. Journal of Gastroenterology and Hepatology 21: 1832-1838.
'Gastric emptying time of fluids and solids in healthy subjects determined by l3C breath tests: influence of age, sex and body mass index ' () 21 Journal of Gastroenterology and Hepatology : 1832 -1838.
-
Huang, Y. and Adams, C.M., 2004. In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria. International Journal of Food Microbiology 91: 253-260.
'In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria ' () 91 International Journal of Food Microbiology : 253 -260.
-
Iyer, C. and Kailasapathy, K., 2005. Effect of co-encapsulation of probiotics with prebiotics on increasing the viability of encapsulated bacteria under in vitro acidic and bile salt conditions and in yogurt. Journal of Food Science 70: m18-m23.
'Effect of co-encapsulation of probiotics with prebiotics on increasing the viability of encapsulated bacteria under in vitro acidic and bile salt conditions and in yogurt ' () 70 Journal of Food Science : m18 -m23.
-
Jensen, H., Grimmer, S., Naterstad, K. and Axelsson, L., 2012. In vitro testing of commercial and potential probiotic lactic acid bacteria. International Journal of Food Microbiology 153: 216-222.
'In vitro testing of commercial and potential probiotic lactic acid bacteria ' () 153 International Journal of Food Microbiology : 216 -222.
-
Kalantzi, L., Goumas, K., Kalioras, V., Abrahamsson, B. and Reppas, C., 2006. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharmaceutical Research 23: 165-176.
'Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies ' () 23 Pharmaceutical Research : 165 -176.
-
Lindahl, A., Ungell, A.L., Knutson, L. and Lennernas, H., 1997. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharmaceutical Research 14: 497-502.
'Characterization of fluids from the stomach and proximal jejunum in men and women ' () 14 Pharmaceutical Research : 497 -502.
-
Lydell, C., Emerson, D. and Gillevet, P.M., 2002. Most probable number techniques recover much higher numbers of bacterial cells than plate counts done from salt marsh sediments. Abstracts of the General Meeting of the American Society for Microbiology 102: 263-263.
'Most probable number techniques recover much higher numbers of bacterial cells than plate counts done from salt marsh sediments ' () 102 Abstracts of the General Meeting of the American Society for Microbiology : 263 -263.
-
McConnell, L.E., Fadda, H.M. and Basit, A.W., 2008. Gut instincts: explorations in intestinal physiology and drug delivery. International Journal of Pharmaceutics 364: 213-226.
'Gut instincts: explorations in intestinal physiology and drug delivery ' () 364 International Journal of Pharmaceutics : 213 -226.
-
Minelli, E.B. and Benini, A., 2008. Relationship between number of bacteria and their probiotic effects. Microbiology and Ecology in Health and Disease 20: 180-183.
'Relationship between number of bacteria and their probiotic effects ' () 20 Microbiology and Ecology in Health and Disease : 180 -183.
-
Mokarram, R.R., Mortazavi, S.A., Najafi, M.B.H. and Shahidi, F. 2009. The influence of multi stage alginate coating on survivability of potential probiotic bacteria in simulated gastric and intestinal juice. Food Research International 42: 1040-1045.
'The influence of multi stage alginate coating on survivability of potential probiotic bacteria in simulated gastric and intestinal juice ' () 42 Food Research International : 1040 -1045.
-
Mudie, D.M., Amidon, G.L. and Amidon, G.E., 2010. Physiological parameters for oral delivery and in vitro testing. Molecular Pharmaceutics 7: 1388-1405.
'Physiological parameters for oral delivery and in vitro testing ' () 7 Molecular Pharmaceutics : 1388 -1405.
-
Nicolaides, E., Galia, E., Efthymiopoulos, C., Dressman, J.B. and Reppas, C., 1999. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data. Pharmaceutical Research 16: 1876-1882.
'Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data ' () 16 Pharmaceutical Research : 1876 -1882.
-
O'Neill, M.A.A. and Gaisford, S., 2011. Application and use of isothermal calorimetry in pharmaceutical development. International Journal of Pharmaceutics 417: 83-93.
'Application and use of isothermal calorimetry in pharmaceutical development ' () 417 International Journal of Pharmaceutics : 83 -93.
-
Oozeer, R., Leplingard, A., Mater, D.D., Mogenet, A., Michelin, R., Seksek, I., Marteau, P., Doré, J., Bresson, J.L. and Corthier, G., 2006. Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Applied Environmental Microbiology 72: 5615-5617.
'Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk ' () 72 Applied Environmental Microbiology : 5615 -5617.
-
Ranadheera, C.S., Evans, C.A., Adams, M.C. and Baines, S.K., 2012. In vitro analysis of gastrointestinal tolerance and intestinal cell adhesion of probiotics in goat's milk ice cream and yogurt. Food Research International 49: 619-625.
'In vitro analysis of gastrointestinal tolerance and intestinal cell adhesion of probiotics in goat's milk ice cream and yogurt ' () 49 Food Research International : 619 -625.
-
Sabikhi, I., Babu, R., Thompkinson, D.K. and Kapila, S., 2010. Resistance of microencapsulated Lactobacillus acidophilus la1 to processing treatments and simulated gut conditions. Food and Bioprocess Technology 3: 586-593.
'Resistance of microencapsulated Lactobacillus acidophilus la1 to processing treatments and simulated gut conditions ' () 3 Food and Bioprocess Technology : 586 -593.
-
Sahadeva, R.P.K., Leong, S.F., Chua, K.H., Tan, C.H., Chan, H.Y., Tong, E.V., Wong, S.Y.W. and Chan, H.K. 2011. Survival of commercial probiotic strains to pH and bile. International Food Research Journal 18: 1515-1522.
'Survival of commercial probiotic strains to pH and bile ' () 18 International Food Research Journal : 1515 -1522.
-
Said, J., Dodoo, C.C., Walker, M., Parsons, D., Stapleton, P., Beezer, A.E. and Gaisford, S., 2014. An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid. International Journal of Pharmaceutics 462: 123-128.
'An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid ' () 462 International Journal of Pharmaceutics : 123 -128.
-
Steingoetter, A., Fox, M., Treier, R., Weishaupt, D., Marincek, B., Boesiger, P., Fried, M. and Schwizer, W., 2006. Effects of posture on the physiology of gastric emptying: a magnetic resonance imaging study. Scandinavian Journal of Gastroenterology 41: 1155-1164.
'Effects of posture on the physiology of gastric emptying: a magnetic resonance imaging study ' () 41 Scandinavian Journal of Gastroenterology : 1155 -1164.
-
Stoianova, L.G. and Arkad'eva, Z.A., 2000. Comparison of methods of storing lactic acid bacteria. Mikrobiologiia 69: 98-104.
'Comparison of methods of storing lactic acid bacteria ' () 69 Mikrobiologiia : 98 -104.
-
Sun, W. and Griffiths, M.W., 2000. Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads. International Journal of Food Microbiology 61: 17-25.
'Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads ' () 61 International Journal of Food Microbiology : 17 -25.
-
United States Pharmacopeia, 2008. United States Pharmacopeia 31, the National Formulary NF 26. United States Pharmacopeial Convention, Inc., Rockville, MD, USA.
-
Vertzoni, M., Dressman, J., Butler, J., Hempenstall, J. and Reppas, C., 2005. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. European Journal of Pharmaceutics and Biopharmaceutics 60: 413-417.
'Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds ' () 60 European Journal of Pharmaceutics and Biopharmaceutics : 413 -417.
-
Wills, R., 2012. In vitro assessment of the survivability of Lactobacillus casei DN-114 001 and Lactobacillus casei Shirota, within commercialised food matrices, in the upper gastrointestinal tract. Plymouth Student Scientist 5: 80-89.
'In vitro assessment of the survivability of Lactobacillus casei DN-114 001 and Lactobacillus casei Shirota, within commercialised food matrices, in the upper gastrointestinal tract ' () 5 Plymouth Student Scientist : 80 -89.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 416 | 404 | 108 |
| PDF Views & Downloads | 438 | 400 | 110 |
Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry
In: Beneficial MicrobesSearch for other papers by M. Fredua-Agyeman in
Current site
Google Scholar
PubMed
Search for other papers by S. Gaisford in
Current site
Google Scholar
PubMed
The large number of probiotic products now available makes the decision about which product to choose difficult both for the consumer and for the specialist providing dietary/nutritional advice. Data on the viability of the bacteria in these products, in an in vivo situation, are therefore important. This study was designed to explore the comparative health and survival of probiotic species in various commercial formulations, using more realistic test systems. This might allow further understanding of factors that must be controlled to optimise the delivery of live healthy bacteria to the lower gut. A total of eight commercially available probiotic preparations were selected for enumeration tests and in vitro gastric tolerance tests. Tolerance assays were conducted in porcine gastric fluid (PGF) fed and fasted state (pH 3.4±0.04), simulated gastric fluid (SGF, pH adjusted to 1.2 and 3.4) and fasted state simulated gastric fluid (FaSSGF, pH adjusted to 1.6 and 3.4). Isothermal microcalorimetry was also used to measure real-time growth of probiotics after exposure to simulated gastric fluid. Results from the enumeration tests indicated that recovery of viable organisms per dose is the same as or better than the stated label claims for liquid-based formulations, but lower than the stated claim for freeze-dried products. Results from the in vitro tolerance tests overall suggest that the PGF provided a harsher environment than the simulated systems at similar pH. In general, liquid-based products tested tended to give superior results in terms of survival compared with the freeze-dried products tested. Results from tests in the fed state in PGF suggested that food greatly affects viability. Microcalorimetric data showed that for some products probiotic species were able to grow following exposure to gastric fluid, suggesting that viable bacteria reach the gut in vivo.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 416 | 404 | 108 |
| PDF Views & Downloads | 438 | 400 | 110 |